Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02148575 · ClinicalTrials.gov registry record · NA

Integrating Palliative Care Into Self-Management of Breast Cancer

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
109
Enrollment target

NCT02148575: Completed NA study, sponsored by Yale University.

NCT02148575 is a NA study that has completed, run by Yale University. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02148575, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target

Study Summary

The purpose of this study is to test a psycho-educational intervention, Managing Cancer Care: A Personal Guide (MCC), that is intended to improve patients' knowledge of palliative care and to facilitate its timely integration into self-management of their breast cancer. The MCC will be tested with patients with Stage I-IV breast cancer at baseline, one, and three months following enrollment. The intervention group will receive the MCC, and the attention-control group will receive a symptom management toolkit. Participants' family caregivers will also be enrolled to provide information on patients' self-management. Investigators hypothesize that users of MCC, as compared to attention-control participants, will demonstrate improved knowledge, feelings, and behaviors related to self-management of their cancer care. This innovative research can help to establish palliative care as a mainstay of self-management interventions that target serious illnesses.

Interventions

  • BEHAVIORAL Self-Management Group
  • BEHAVIORAL Symptom Management Group

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2014-06
Est. Completion 2017-01
Phase NA
Yale University

1,492 total trials

What the finished NCT02148575 record still lists

NCT02148575 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Self-Management Group is the first listed.

NCT02148575 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02148575 about?

NCT02148575 is a clinical study titled "Integrating Palliative Care Into Self-Management of Breast Cancer". The purpose of this study is to test a psycho-educational intervention, Managing Cancer Care: A Personal Guide (MCC), that is intended to improve patients' knowledge of palliative care and to facilitate its timely integration into self-management of their breast cancer. The MCC will be tested with p...

What is the current status of trial NCT02148575?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2014-06. Estimated completion is 2017-01.

What interventions are being tested in trial NCT02148575?

The interventions under investigation include: Self-Management Group (BEHAVIORAL), Symptom Management Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02148575?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02148575's enrollment target sits among peer trials

109 825th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02148575, the US trial registry maintained by the National Library of Medicine. NCT02148575 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.